Vertex Pharmaceuticals Inc. closed 10.29% short of its 52-week high of $519.88, which the company achieved on November 8th.

Vertex, Inc. (NASDAQ: VERX) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Joe Crivelli - Vice President of Investor Relations David DeStefano - President and Chief ...

Vertex Inc. reported its first-quarter 2025 earnings, surpassing analyst expectations with an earnings per share (EPS) of $0.15, compared to the forecasted $0.13. Despite this positive performance ...

NetApp Partners With Google Cloud to Simplify Scaling High-Performance Workloads in the CloudNew features for Google Cloud NetApp Volumes improve support for large workloads, including Vertex ...

Bruker Corporation announced the launch of the VERTEX NEO Platform with its first product, the VERTEX NEO R. This release marks a continuation of providing high-end Fourier-Transform Infrared (FTIR) ...

For the current fiscal year, Vertex is expected to post earnings of $0.70 per share on $664.94 million in revenues. Meanwhile, for the next fiscal year, the company is expected to earn $0.89 per ...

Vertex Inc stock soars to all-time high of $43.58 Company News Published 11/04/2024, 09:31 AM 0 ...

CHANGZHOU, China, July 18, 2024 /PRNewswire/ -- Trinasolar's Vertex N 720W series module has achieved top ranking in a PV Magazine test, demonstrating its excellent performance in all categories ...

Trinasolar's Vertex N 720W series module has achieved top ranking in a PV Magazine test, demonstrating its excellent performance in all categories in indoor performance tests. Alongside the Vertex ...

Vertex Pharmaceuticals shares hit a record high after the results of a pain medicine study and announcing a gene-editing technology agreement. The Phase 2 trial of its VX-548 medicine showed ...